Tag: KALV

Analysts Viewpoint

In a filing, KalVista Pharmaceuticals Inc revealed its CHIEF SCIENTIFIC OFFICER Feener Edward P. unloaded Company’s shares for reported $0.4

Stock Earnings

KalVista Pharmaceuticals Inc’s filing revealed that its CHIEF SCIENTIFIC OFFICER Feener Edward P. unloaded Company’s shares for reported $0.4 million